FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.10.2022
End date : 31.05.2025
Extension date: 30.09.2025
Reactive carbonyl species (RCS) are linked to development of metabolic syndrome including neuropathic pain and steatotic liver disease (MASLD), but the possibly synergistic role of RCS in both conditions remains to be investigated. This project aims at analyzing RCS as biomarkers in patients with neuropathy and neuropathic pain, with parallel compre¬hensive experimental neurophysiological examinations of pa¬tients and assessment of functional effects of RCS on sensory neurons in vitro.